EP Patent

EP0953359A4 — Pharmaceutical composition for oral administration

Assigned to Daiichi Pharmaceutical Co Ltd · Expires 2001-12-19 · 24y expired

What this patent protects

Patent listed against carvedilol-phosphate.

Drugs covered by this patent

carvedilol-phosphate (CARVEDILOL PHOSPHATE)

Patent Metadata

Patent number: EP0953359A4
Jurisdiction: EP
Classification: —
Expires: 2001-12-19
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.